Mostrar registro simples

dc.contributor.authorLima, Elis Costa dept_BR
dc.contributor.authorBoza, Juliana Catuccipt_BR
dc.contributor.authorPalominos, Penelope Estherpt_BR
dc.contributor.authorXavier, Ricardo Machadopt_BR
dc.contributor.authorCestari, Tania Ferreirapt_BR
dc.date.accessioned2022-07-28T04:44:41Zpt_BR
dc.date.issued2021pt_BR
dc.identifier.issn0365-0596pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/245577pt_BR
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofAnais brasileiros de dermatologia. Rio de Janeiro. Vol. 96, n. 3 (2021), p. 376-379.pt_BR
dc.rightsOpen Accessen
dc.subjectPsoríasept_BR
dc.subjectTratamento farmacológicopt_BR
dc.subjectSobrevidapt_BR
dc.titleSurvival of immunobiological drugs in psoriasis : preliminary data from a tertiary hospital experience in Southern Brazilpt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001146347pt_BR
dc.type.originNacionalpt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples